Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
The invention refers to the use of a sigma ligand, preferably a sigma ligand of formula (I), to prevent or treat emesis induced by a chemotherapeutic agent or radioactivity, especially emesis induced by taxanes, vinca alkaloids or platin chemotherapeutic drugs.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
10.10.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!